The FDA intends to authorize booster shots of the Pfizer-BioNTech COVID-19 vaccine for all adults this week — potentially as early as Thursday.
Last week, Pfizer asked the FDA to authorize booster doses for ages 18 and older who received a second vaccine dose at least 6 months ago. Several top health officials in the Biden administration have recommended the plan to fight against another increase in coronavirus cases, especially before people gather for holiday celebrations, the newspaper reported.
And in other states, adults have found ways to get an extra dose, even if they didn’t qualify yet, according to theIn September, the FDA approved boosters for ages 65 and older, adults with underlying health conditions or those with high risks for contracting COVID-19 due to their jobs or living situations. In October, booster doses were also authorized for those who received the one-shot Johnson & Johnson vaccine and vulnerable groups who received the Moderna vaccine..
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA Could Reportedly Sign Off On Pfizer Covid Booster Shots For All Adults This WeekMillions of additional Americans could become eligible for an extra dose of Pfizer’s coronavirus vaccine as early as Thursday, the New York Times and NBC report.
続きを読む »
FDA Will Authorize Pfizer COVID Booster Shot for All Adults: ReportThe move is expected within days, after several states and New York City made the extra shots available over the past week.
続きを読む »
Pfizer asks FDA to authorize Covid antiviral pillsPfizer asked the FDA to authorize its oral Covid antiviral pill called Paxlovid. The treatment is highly effective in reducing the risk of hospitalization.
続きを読む »
FDA expected to authorize Pfizer COVID-19 booster for all adults this weekThe move could come as early as Thursday.
続きを読む »